The next big thing in pharma might not be something you like
Hospitals competing on pharma’s turf by supplying their own generics signals a tectonic shift, and don’t expect it to go away anytime soon.
Print Issue: March 01, 2020
Read the March 2020 digital edition
This issue includes the 2020 MM&M/Elevate Healthcare Marketers Trend report and features on online health communities and behavioral marketing campaigns.
Two behavioral marketing campaigns illustrate challenges resonating with patients
There are many challenges that come with identifying and deploying insights that resonate with patients, but the two behavioral marketing campaigns examined successfully thread the needle.
ePharma reinvents itself as Pharma IMPACT
Pharma IMPACT prepares for a dual-track approach on March 18 and 19 in New York City.
MM&M debunks six popular misconceptions around online health communities
Despite their increasing scale and intensified interest from medical marketers, digital health communities are still misunderstood. We thought it was time to clear up six of the biggest misconceptions.
A retrospective look at the last 3 years of MM&M’s Healthcare Marketers Trend Report
We tease out the overarching trends in four areas: budget, audience, tactics and the forces impacting industry.
MM&M/Elevate Healthcare Marketers Trend Report: Budgets up 16%, industry optimistic about growth opportunities
With budgets up yet again, industry marketers are drowning out the political noise and pouncing on the opportunities that present themselves.
Elevate’s Powers looks to the future after a positive Trend Report
Industry veteran Frank X. Powers, Elevate Healthcare’s cofounder and managing partner, has witnessed how pharmaceutical, device and diagnostics companies have contended with the ebb and flow of marketing budgets over the years.
A new deal with healthcare marketers, but let’s not shake on it
A recent trip to the West Coast for a health conference showed the importance of personal experience in health marketing, with or without handshakes.
MannKind version 2.0: CEO Michael Castagna faces his biggest test yet with Afrezza reboot
MannKind has rebranded for the first time in 20 years as CEO Michael Castagna looks to lead the company’s turnaround.
